Albany Molecular Research, Inc. (AMRI) Announces Research and Licensing Agreement with Genentech
(BUSINESS WIRE)--AMRI announced today a research and licensing agreement with Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), for a family of antibacterial compounds discovered from AMRI’s proprietary research of its natural products sample collection.